Articles on Biotechnology
Displaying 21 - 40 of 105 articles
The three flu pandemics of the 20th century originated from birds, making it critical to fight bird flu. Breakthroughs in gene-editing chickens show promise for eliminating the disease in the future.
Beyond ordinary consumption, new research finds uses for kola nut in areas like agriculture and health.
Genetically modified crops are increasing yield and food security in developed countries, but in Africa, a lack of adoption is limiting success.
Neuralink might get all the press – but these unsung heroes are pioneering brain-computer interface technology.
The biotech sector uses climate change as an urgent argument for more funding and fewer regulatory hurdles. But the urgency of climate change raises the risk of superficial claims and actions.
Some might argue ‘moral enhancement’ medicine already exists — such as when we take medicine that alters our brain chemistry. Where do we draw a line?
Nigeria can save money spent importing citric acid by producing it from cashew waste.
Record-breaking technology can sequence an entire human genome in a matter of hours. The work could be a lifeline for people suffering from the more than 5,000 known rare genetic diseases.
Scientists are looking for safe new ways to prevent ice from damaging food in frozen storage, which costs consumers billions of dollars a year in wasted food.
The FDA approved Alzheimer’s disease drug aducanumab despite minimal evidence of its efficacy. Whether this decision ultimately hurts or helps patients depends on data researchers don’t yet have.
We may never know whether the pandemic began with a leak at the Wuhan lab. But even the possibility shows we need a universal biosafety code to prevent something similar happening in future.
Skyrocketing demand coupled with shortages of vital components is leading to bottlenecks in the supply chain of Pfizer’s and other mRNA vaccines.
We have two mRNA COVID-19 vaccines so far. But what else can this technology do?
Plant scientists hope to avoid a repeat of the GM foods debate from two decades ago.
Medical innovation is often accelerated in a time of crisis.
Global long-term data simply doesn’t exist for jellyfish, so scientists struggle to predict, track and mitigate their potential effects.
COVID-19 tests rely on a process developed at a biotech company co-founded by a Canadian. Canada’s current testing expertise needs to be channelled to prepare for the next wave, and the next pandemic.
The results from the phase 1 trial are a promising first step in showing that the mRNA vaccine is a viable candidate, but there are unanswered questions and it is still early in the process.
A new biotech regulation allows companies to self-police and decide which crops should be regulated. The new rule is likely to amplify greater distrust of GM crops.
Biohackers and other ‘connoisseurs of science’ have important social and scientific contributions to make.



















